Search research articles
Contact Us
Filters
Showing results (21-30 of 32) with videos related to
Page
of 4
Sort By:
Aging and Disease
|
June 29, 2026
Targeting Cellular Senescence as a Therapeutic Strategy to Attenuate Pulmonary Fibrosis Associated with Metabolic Syndrome
Michaela Rennerova, Tereza Havrlantova, Igor Simonik, et al.
Antioxidants & Redox Signaling
|
September 10, 2011
Mitochondrially targeted α-tocopheryl succinate is antiangiogenic: potential benefit against tumor angiogenesis but caution against wound healing
Jakub Rohlena, Lan-Feng Dong, Katarina Kluckova, et al.
Aging Cell
|
May 10, 2018
Metformin directly targets the H3K27me3 demethylase KDM6A/UTX
Elisabet Cuyàs, Sara Verdura, Laura Llorach-Pares, et al.
Therapeutic Advances in Medical Oncology
|
October 3, 2023
Mitochondrially targeted tamoxifen as anticancer therapy: case series of patients with renal cell carcinoma treated in a phase I/Ib clinical trial
Zuzana Bielcikova, Lukas Werner, Jan Stursa, et al.
Plos One
|
May 2, 2015
Characterisation of mesothelioma-initiating cells and their susceptibility to anti-cancer agents
Elham Alizadeh Pasdar, Michael Smits, Michael Stapelberg, et al.
Plos One
|
May 18, 2016
Correction: Characterisation of Mesothelioma-Initiating Cells and Their Susceptibility to Anti-Cancer Agents
Elham Alizadeh Pasdar, Michael Smits, Michael Stapelberg, et al.
Nature Communications
|
April 7, 2022
Mitochondrially targeted tamoxifen alleviates markers of obesity and type 2 diabetes mellitus in mice
Eliska Vacurova, Jaroslava Trnovska, Petr Svoboda, et al.
Antioxidants & Redox Signaling
|
July 10, 2016
Selective Disruption of Respiratory Supercomplexes as a New Strategy to Suppress Her2<sup>high</sup> Breast Cancer
Katerina Rohlenova, Karishma Sachaphibulkij, Jan Stursa, et al.
Eclinicalmedicine
|
April 17, 2023
Mitochondrially targeted tamoxifen in patients with metastatic solid tumours: an open-label, phase I/Ib single-centre trial
Zuzana Bielcikova, Jan Stursa, Ludmila Krizova, et al.
Free Radical Biology & Medicine
|
October 23, 2013
Indoleamine-2,3-dioxygenase elevated in tumor-initiating cells is suppressed by mitocans
Michael Stapelberg, Renata Zobalova, Maria Nga Nguyen, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 32) with videos related to
Sort By:
Page
of 4
Aging and Disease
|
June 29, 2026
Targeting Cellular Senescence as a Therapeutic Strategy to Attenuate Pulmonary Fibrosis Associated with Metabolic Syndrome
Michaela Rennerova, Tereza Havrlantova, Igor Simonik, et al.
Antioxidants & Redox Signaling
|
September 10, 2011
Mitochondrially targeted α-tocopheryl succinate is antiangiogenic: potential benefit against tumor angiogenesis but caution against wound healing
Jakub Rohlena, Lan-Feng Dong, Katarina Kluckova, et al.
Aging Cell
|
May 10, 2018
Metformin directly targets the H3K27me3 demethylase KDM6A/UTX
Elisabet Cuyàs, Sara Verdura, Laura Llorach-Pares, et al.
Therapeutic Advances in Medical Oncology
|
October 3, 2023
Mitochondrially targeted tamoxifen as anticancer therapy: case series of patients with renal cell carcinoma treated in a phase I/Ib clinical trial
Zuzana Bielcikova, Lukas Werner, Jan Stursa, et al.
Plos One
|
May 2, 2015
Characterisation of mesothelioma-initiating cells and their susceptibility to anti-cancer agents
Elham Alizadeh Pasdar, Michael Smits, Michael Stapelberg, et al.
Plos One
|
May 18, 2016
Correction: Characterisation of Mesothelioma-Initiating Cells and Their Susceptibility to Anti-Cancer Agents
Elham Alizadeh Pasdar, Michael Smits, Michael Stapelberg, et al.
Nature Communications
|
April 7, 2022
Mitochondrially targeted tamoxifen alleviates markers of obesity and type 2 diabetes mellitus in mice
Eliska Vacurova, Jaroslava Trnovska, Petr Svoboda, et al.
Antioxidants & Redox Signaling
|
July 10, 2016
Selective Disruption of Respiratory Supercomplexes as a New Strategy to Suppress Her2<sup>high</sup> Breast Cancer
Katerina Rohlenova, Karishma Sachaphibulkij, Jan Stursa, et al.
Eclinicalmedicine
|
April 17, 2023
Mitochondrially targeted tamoxifen in patients with metastatic solid tumours: an open-label, phase I/Ib single-centre trial
Zuzana Bielcikova, Jan Stursa, Ludmila Krizova, et al.
Free Radical Biology & Medicine
|
October 23, 2013
Indoleamine-2,3-dioxygenase elevated in tumor-initiating cells is suppressed by mitocans
Michael Stapelberg, Renata Zobalova, Maria Nga Nguyen, et al.
Page
of 4